Home › NDC Lookup › RxCUI directory › RxCUI 1429282

Neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz] — RxCUI 1429282

RxNorm drug concept · Semantic branded drug
RxCUI 1429282 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1429282
Official nameNeostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBloxiverz 0.5 MG/ML Injectable Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)65 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Neostigmine Methylsulfate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • During surgery, you may be given a muscle relaxant to keep your muscles completely still — including your breathing muscles. When the procedure is over, the care team needs those m...
  • What exactly does neostigmine methylsulfate do during or after surgery?
  • Neostigmine is given directly into a vein by the anesthesia team, so you won't feel a needle stick in the usual sense. Some people experience nausea, increased saliva, or a slow or...
  • Yes — it's important to tell your anesthesia team if you have heart disease, irregular heart rhythms, or had a recent heart attack, because neostigmine can affect your heart rate a...
📖 Read our full Neostigmine Methylsulfate guide →

🕸️ Concept Web — How Neostigmine methylsulfate 0.5 MG/ML Injectable S... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz] RxCUI 1429282

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Neostigmine 7315
    • Neostigmine methylsulfate 7316
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bloxiverz 1429278
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Neostigmine Injectable Solution 373043
    • Neostigmine methylsulfate Injectable Solution 2647582
    • Neostigmine Injectable Product 1157557
    • Neostigmine methylsulfate Injectable Product 2659497
    • Neostigmine Injectable Solution [Bloxiverz] 1429280
    • Neostigmine methylsulfate Injectable Solution [Bloxiverz] 2658583
    • Bloxiverz Injectable Product 1429281
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Neostigmine methylsulfate 0.5 MG/ML Injectable Solution SCD · 311935
  • Neostigmine methylsulfate 0.5 MG/ML SCDC · 1649889
  • Neostigmine Injectable Solution SCDF · 373043
  • Neostigmine methylsulfate Injectable Solution SCDFP · 2647582
  • Neostigmine Injectable Product SCDG · 1157557
  • Neostigmine methylsulfate Injectable Product SCDGP · 2659497

Brand-Name Concepts

  • Neostigmine methylsulfate 0.5 MG/ML [Bloxiverz] SBDC · 1649891
  • Neostigmine Injectable Solution [Bloxiverz] SBDF · 1429280
  • Neostigmine methylsulfate Injectable Solution [Bloxiverz] SBDFP · 2658583
  • Bloxiverz Injectable Product SBDG · 1429281
  • Bloxiverz BN · 1429278

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1429282 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51754-1200-03 10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1... Bloxiverz Exela Pharma Sciences, LLC 2023-12-31
Observed labelers: Exela Pharma Sciences, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.